tiprankstipranks
AbbVie significantly outspent rivals to promote drugs in 2023, STAT says
PremiumThe FlyAbbVie significantly outspent rivals to promote drugs in 2023, STAT says
16d ago
Cerevel Therapeutics weakness attributed to CTFN report
PremiumThe Fly
Cerevel Therapeutics weakness attributed to CTFN report
18d ago
5 Strong Buy Dividend Stocks for July
PremiumStock Analysis & Ideas
5 Strong Buy Dividend Stocks for July
19d ago
FDA grants second approval for EPKINLY in r/r follicular lymphoma
PremiumThe FlyFDA grants second approval for EPKINLY in r/r follicular lymphoma
25d ago
FDA grands second approval for AbbVie’s EPKINLY in follicular lymphoma Genmab
PremiumThe Fly
FDA grands second approval for AbbVie’s EPKINLY in follicular lymphoma Genmab
25d ago
AbbVie provides U.S. regulatory update on ABBV-951
PremiumThe Fly
AbbVie provides U.S. regulatory update on ABBV-951
26d ago
AbbVie Recommends Shareholders Reject Tutanota’s “Mini-Tender” Offer
PremiumPress ReleasesAbbVie Recommends Shareholders Reject Tutanota’s “Mini-Tender” Offer
1M ago
AbbVie recommends shareholders reject Tutanota’s ‘mini-tender’ offer
PremiumThe Fly
AbbVie recommends shareholders reject Tutanota’s ‘mini-tender’ offer
1M ago
MRK, ABBV, LI: 3 Low-Beta Stocks with Upside Potential
PremiumMarket News
MRK, ABBV, LI: 3 Low-Beta Stocks with Upside Potential
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100